Walleye Capital LLC Amarin Corp Plcuk Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $15,600 - $83,967	-3,900 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $437,716 - $757,368	-31,400 Reduced 88.95%	3,900 $84,000
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $490,317 - $817,548	35,300 New	35,300 $535,000
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $274,963 - $346,619	-16,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $213,109 - $377,377	16,900 New	16,900 $351,000

178

65.3M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.